Jun 11, 2026 07:03AM
Jun 11, 2026 07:03AM
Jun 11, 2026 07:02AM
Jun 11, 2026 07:00AM
Jun 4, 2026 04:01PM
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes
Jun 2, 2026 04:01PM
Jun 2, 2026 04:01PM
Jun 1, 2026 07:00AM
Jun 1, 2026 07:00AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM
May 20, 2026 07:00AM Syndax Announces Participation in Upcoming Investor Conferences
May 12, 2026 10:31AM
May 6, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 24, 2026 07:00AM
Apr 3, 2026 04:01PM
Mar 4, 2026 04:01PM
Feb 26, 2026 04:01PM Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 23, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 5, 2026 07:00AM
Feb 4, 2026 04:01PM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Jan 7, 2026 07:00AM Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.
Jan 5, 2026 07:00AM
Dec 12, 2025 07:00AM
Dec 9, 2025 04:34AM
Dec 8, 2025 06:50AM
Dec 8, 2025 06:50AM
Dec 3, 2025 04:01PM
Dec 1, 2025 07:00AM Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference
Nov 5, 2025 04:01PM
Nov 3, 2025 04:01PM
Nov 3, 2025 09:09AM
Nov 3, 2025 09:08AM
Nov 3, 2025 09:08AM
Oct 30, 2025 07:00AM
Oct 27, 2025 07:48AM Syndax Pharmaceuticals' (SNDX) Revuforj Expansion a Long-term Growth Lever- Stifel
Oct 27, 2025 07:00AM
Oct 24, 2025 01:59PM
Oct 24, 2025 01:58PM
Oct 24, 2025 01:08PM
Oct 3, 2025 04:01PM
Sep 19, 2025 07:00AM
Sep 19, 2025 07:00AM Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
Aug 26, 2025 07:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All